MA Boston의 대장직장암 임상 시험
대장직장암 관련 연구 63개가 Boston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
피험자 모집 중2상
- Boston Medical Center, Boston
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
피험자 모집 중2상
- Dana-Farber Cancer Institute - Oncology Department, Boston
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
피험자 모집 중1상
- Exelixis Clinical Site #7, Boston
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
피험자 모집 중1상
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Insitute, Boston
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
피험자 모집 중1/2상
- Dana-Farber Cancer Institute, Boston
The Impact of PReOPerative Exercise and NutritionaL Optimization on Perioperative Outcomes for Patients Undergoing Treatment for Rectal Cancer: The PROPEL Trial
피험자 모집 중
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
피험자 모집 중1상
- Research Site, Boston
- Research Site, Boston
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
피험자 모집 중1상
- Massachusetts General Hospital, Boston
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
피험자 모집 중2상
- Dana-Farber Cancer Institute /ID# 270624, Boston
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
피험자 모집 중3상
- Brigham and Women's Hospital (BWH), Boston
- Dana-Farber Cancer Institute (DFCI), Boston
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
피험자 모집 중1상
- Research Site, Boston
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
피험자 모집 중1/2상
- Tufts Medical Center, Boston
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
피험자 모집 중1/2상
- Dana Farber Cancer Institute, Boston
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
피험자 모집 중1상
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
피험자 모집 중1상
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
피험자 모집 중1/2상
- Massachusetts General Hospital - Main Campus, Boston
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
피험자 모집 중1상
- Dana-Farber Cancer Institute, Boston
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
피험자 모집 중1/2상
- Dana-Farber Cancer Institute, Boston
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
피험자 모집 중3상
- Massachusetts General Hospital, Boston
- Oncura Health, Boston
Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial
피험자 모집 중
- Dana Farber Cancer Institute, Boston
Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
피험자 모집 중2상
- Brigham and Women's Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- Massachusetts General Hospital (MG), Boston
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
피험자 모집 중1상
- Dana-Farber Cancer Institute, Boston
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
피험자 모집 중1상
- Mass General Cancer Center, Boston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
피험자 모집 중1/2상
- Dana-Farber Cancer Institute, Boston
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
피험자 모집 중1상
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
피험자 모집 중관찰 연구
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
피험자 모집 중1/2상
- Massachusetts General Hospital Cancer Center, Boston
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
피험자 모집 중1상
- Massachusetts General Hospital, Boston
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
피험자 모집 중1상
- Massachusetts General Hospital, Boston
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
피험자 모집 중1/2상
- Massachusetts General Hospital - Dana Farber, Boston
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
피험자 모집 중1상
- Dana Farber Cancer Institute, Boston
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
피험자 모집 중1상
- Beth Israel Deaconess Medical Center, Boston
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
피험자 모집 중2상
- Massachusetts General Hospital /ID# 273608, Boston
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
피험자 모집 중1상
- Dana-Farber/Massachusetts General Hospital, Inc, Boston
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
피험자 모집 중1상
- Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston
A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
피험자 모집 중1/2상
- Massachusetts General Hospital Cancer Center, Boston
BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention
피험자 모집 중
- Massachusetts General Hospital Cancer Center, Boston
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
피험자 모집 중1상
- Research Site, Boston
- Research Site, Boston
LYL273 for Patients With Relapsed or Refractory mCRC
피험자 모집 중1/2상
- Dana-Farber Cancer Institute, Boston
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
피험자 모집 중1상
- Dana-Farber Cancer Institute, Boston
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
피험자 모집 중1상
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
피험자 모집 중1상
- Massachusetts General Hospital, Boston
Video Education With Result Dependent dIsclosure
피험자 모집 중
- Dana Farber Cancer Institute, Boston
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
피험자 모집 중1/2상
- Dana Farber Cancer Institute, Boston
Botensilimab, Balstilimab, and SBRT in Colorectal Cancer
피험자 모집 중초기 1상
- Massachusetts General Hospital, Boston
COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
Remote Monitoring and Symptom Management Digital Application
피험자 모집 중
- Massachusetts General Hospital, Boston
A Study of MGC028 in Participants With Advanced Solid Tumors
피험자 모집 중1상
- Mass General Brigham, Boston
- Dana Farber/Harvard Cancer Center, Boston
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
피험자 모집 중1상
- Dana Farber Cancer Institute, Boston
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
피험자 모집 중1상
- Dana Farber Cancer Institute, Boston
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
피험자 모집 중1/2상
- Dana-Farber Cancer Institute, Boston
Pathways, Risk Factors, and mOleculeS to Prevent Early-onset Colorectal Tumors
피험자 모집 중1상
- Massachusetts General Hospital Cancer Center, Boston
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
피험자 모집 중4상
- Massachussets General Hospital, Boston
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
피험자 모집 중1/2상
- Massachusetts General Hospital, Boston
Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
피험자 모집 중건강한 지원자 환영
- Codman Square Health Center, Boston
- East Boston Neighborhood Health Center, East Boston · 2마일 거리
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
피험자 모집 중1상
- Dana Farber/Partners Cancer Care Inc, Boston
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
피험자 모집 중3상
- Massachusetts General Hospital, Boston
다른 도시의 대장직장암 시험
- Houston, TX연구 102개
- New York City, NY연구 77개
- Nashville, TN연구 69개
- Los Angeles, CA연구 59개
- Arlington, VA연구 52개
- St. Louis, MO연구 50개
- San Antonio, TX연구 46개
- Philadelphia, PA연구 44개
- Grand Rapids, MI연구 40개
- Baldwin Park, CA연구 38개
- Seattle, WA연구 34개
- Tampa, FL연구 33개
Boston의 다른 연구
- 유방암연구 111개
- 비소세포폐암연구 90개
- 암 (전체)연구 86개
- 전이성 암연구 63개
- 폐암연구 62개
- 난소암연구 61개
- 전립선암연구 59개
- 우울증연구 52개
- 자궁내막암연구 50개
- 심부전연구 44개
- 급성 골수성 백혈병연구 44개
- 췌장암연구 43개
ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.